Comparative multiple-dose pharmacokinetics of controlled-release levodopa products.

Clinical pharmacokinetics of levodopa in parkinson's disease.

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations.

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.

Central pharmacokinetics of levodopa: Lessons from imaging studies.

Pharmacokinetics of vinyldithiins, transformation products of allicin.

Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets.

Comparative studies of pharmacokinetics and anticoagulatory effect in rats after oral administration of Frankincense and its processed products.

Comparative pharmacokinetics of captopril, enalapril, and quinapril.

Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)).

Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa.

The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers.

Comparative analysis of GOCI ocean color products.

Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease.

carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.

Pharmacokinetics of Levodopa before and after Gastrointestinal Resection in Parkinson's Disease.

No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease.

Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease.

Levodopa.

Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety.

Levodopa.

Comparative pharmacokinetics of coumarin anticoagulants XV: relationship between pharmacokinetics of dicumarol and warfarin in rats.

Comparative anticonvulsant potency and pharmacokinetics of (+)-and (-)-enantiomers of stiripentol.

Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin.

Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta.

Suggest Documents

Clinical pharmacokinetics of levodopa in parkinson's disease.

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations.

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.

Central pharmacokinetics of levodopa: Lessons from imaging studies.

Pharmacokinetics of vinyldithiins, transformation products of allicin.

Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets.

Comparative studies of pharmacokinetics and anticoagulatory effect in rats after oral administration of Frankincense and its processed products.

Comparative pharmacokinetics of captopril, enalapril, and quinapril.

Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)).

Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa.

The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers.

Comparative analysis of GOCI ocean color products.

Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease.

carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.

Pharmacokinetics of Levodopa before and after Gastrointestinal Resection in Parkinson's Disease.

No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease.

Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease.

Levodopa.

Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety.

Levodopa.

Comparative pharmacokinetics of coumarin anticoagulants XV: relationship between pharmacokinetics of dicumarol and warfarin in rats.

Comparative anticonvulsant potency and pharmacokinetics of (+)-and (-)-enantiomers of stiripentol.

Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin.

Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta.

Comparative multiple-dose pharmacokinetics of controlled-release levodopa products.

Recommend Documents

Follow Us